ClinicalTrials.Veeva

Menu

Cystic Fibrosis (CF) Flow Rates Study

S

Syntara

Status

Completed

Conditions

Cystic Fibrosis

Study type

Observational

Funder types

Industry

Identifiers

NCT00779077
DPM-OSM-403

Details and patient eligibility

About

We wish to measure the inspiratory flow and volumes generated by the subjects inhaling from a spirometer with a high resistance dry powder inhaler in series in subjects with cystic fibrosis.

Enrollment

25 patients

Sex

All

Ages

6 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CF
  • FEV1 ≥ 30% and < 90% predicted

Exclusion criteria

  • Be considered "terminally ill" or listed for lung transplantation
  • Have had a lung transplant
  • Have had a significant episode of haemoptysis (>60 ml) in the three months prior to enrolment
  • Have had a myocardial infarction in the three months prior to enrolment
  • Have had a cerebral vascular accident in the three months prior to enrolment
  • Have had major ocular surgery in the three months prior to enrolment
  • Have had major abdominal, chest or brain surgery in the three months prior to enrolment
  • Have a known cerebral, aortic or abdominal aneurysm
  • Be breast feeding or pregnant
  • Be using beta blockers
  • Have unstable asthma

Trial design

25 participants in 1 patient group

cystic fibrosis
Description:
adults and children with cystic fibrosis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems